Cowen Prime Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$475K Buy
63,040
+1,000
+2% +$7.53K 0.16% 61
2023
Q1
$542K Sell
62,040
-3,000
-5% -$26.2K 0.22% 57
2022
Q4
$593K Buy
65,040
+24,300
+60% +$222K 0.24% 56
2022
Q3
$329K Hold
40,740
0.19% 55
2022
Q2
$306K Buy
40,740
+10,000
+33% +$75.1K 0.17% 60
2022
Q1
$289K Sell
30,740
-300
-1% -$2.82K 0.12% 74
2021
Q4
$249K Sell
31,040
-50,254
-62% -$403K 0.08% 76
2021
Q3
$792K Hold
81,294
0.29% 56
2021
Q2
$805K Hold
81,294
0.29% 52
2021
Q1
$938K Hold
81,294
0.35% 52
2020
Q4
$784K Hold
81,294
0.35% 46
2020
Q3
$732K Buy
81,294
+40,554
+100% +$365K 0.36% 46
2020
Q2
$306K Sell
40,740
-40,554
-50% -$305K 0.17% 60
2020
Q1
$730K Hold
81,294
0.45% 43
2019
Q4
$797K Sell
81,294
-860
-1% -$8.43K 0.36% 43
2019
Q3
$565K Hold
82,154
0.29% 51
2019
Q2
$758K Hold
82,154
0.37% 48
2019
Q1
$1.29M Sell
82,154
-1,750
-2% -$27.4K 0.67% 40
2018
Q4
$1.29M Buy
83,904
+17,350
+26% +$268K 0.78% 37
2018
Q3
$1.43M Sell
66,554
-550
-0.8% -$11.9K 0.67% 46
2018
Q2
$1.63M Sell
67,104
-3,335
-5% -$81.1K 0.8% 35
2018
Q1
$1.2M Sell
70,439
-700
-1% -$12K 0.67% 45
2017
Q4
$1.35M Sell
71,139
-74,700
-51% -$1.42M 0.66% 45
2017
Q3
$2.57M Sell
145,839
-3,600
-2% -$63.4K 1.22% 26
2017
Q2
$4.96M Buy
149,439
+300
+0.2% +$9.97K 2.29% 14
2017
Q1
$4.79M Buy
149,139
+7,900
+6% +$254K 2.46% 13
2016
Q4
$5.12M Buy
141,239
+700
+0.5% +$25.4K 2.76% 11
2016
Q3
$6.47M Buy
140,539
+3,200
+2% +$147K 2.94% 6
2016
Q2
$6.9M Sell
137,339
-200
-0.1% -$10K 3.35% 6
2016
Q1
$7.36M Buy
137,539
+400
+0.3% +$21.4K 3.41% 8
2015
Q4
$9M Hold
137,139
3.97% 7
2015
Q3
$7.74M Sell
137,139
-1,590
-1% -$89.8K 3.61% 6
2015
Q2
$8.2M Sell
138,729
-1,756
-1% -$104K 3.21% 6
2015
Q1
$8.75M Sell
140,485
-691
-0.5% -$43K 3.6% 7
2014
Q4
$8.12M Buy
141,176
+2,807
+2% +$161K 3.2% 8
2014
Q3
$7.44M Buy
138,369
+10
+0% +$537 3.25% 8
2014
Q2
$7.25M Sell
138,359
-290
-0.2% -$15.2K 2.85% 8
2014
Q1
$7.33M Buy
138,649
+35,385
+34% +$1.87M 2.77% 10
2013
Q4
$4.14M Buy
103,264
+1,414
+1% +$56.7K 1.59% 18
2013
Q3
$3.85M Buy
101,850
+2,117
+2% +$80K 1.5% 16
2013
Q2
$3.89M Buy
+99,733
New +$3.89M 1.62% 13